PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 33 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $552,164 | +562.9% | 276,082 | +596.0% | 0.00% | – |
| Q1 2023 | $83,296 | -34.1% | 39,665 | -57.0% | 0.00% | – |
| Q4 2022 | $126,340 | +54.1% | 92,219 | +17.5% | 0.00% | – |
| Q3 2022 | $82,000 | -9.9% | 78,476 | -6.1% | 0.00% | – |
| Q2 2022 | $91,000 | -40.9% | 83,556 | -42.5% | 0.00% | – |
| Q1 2022 | $154,000 | +116.9% | 145,208 | +69.5% | 0.00% | – |
| Q4 2021 | $71,000 | -79.8% | 85,658 | -67.7% | 0.00% | – |
| Q3 2021 | $352,000 | -55.6% | 265,249 | -36.1% | 0.00% | – |
| Q2 2021 | $792,000 | +80.4% | 414,965 | +321.2% | 0.00% | – |
| Q1 2021 | $439,000 | +442.0% | 98,528 | +343.5% | 0.00% | – |
| Q4 2020 | $81,000 | +42.1% | 22,218 | +51.5% | 0.00% | – |
| Q3 2020 | $57,000 | -89.5% | 14,661 | -89.8% | 0.00% | – |
| Q2 2020 | $542,000 | +337.1% | 143,821 | +185.6% | 0.00% | – |
| Q1 2020 | $124,000 | +18.1% | 50,352 | +53.4% | 0.00% | – |
| Q4 2019 | $105,000 | – | 32,824 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 2,470,332 | $8,967,000 | 6.83% |
| Psagot Value Holdings Ltd. | 470,255 | $1,707,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 212,591 | $772,000 | 0.02% |
| UBS OCONNOR LLC | 150,000 | $544,000,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 10,042 | $36,000 | 0.01% |
| Renaissance Technologies | 488,634 | $1,774,000 | 0.00% |
| Squarepoint Ops LLC | 22,068 | $80,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 222 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 50,280 | $183,000 | 0.00% |